丹特烯的当前临床应用
Hong Seuk Yang1, Jae Moon Choi2, Junyong In3
1Department of Anesthesiology and Pain Medicine, Daejeon Eulji Medical Center, Eulji University, School of Medicine, Daejeon, Korea.
Anesthesia and pain medicine
|September 11, 2023
概括
丹特罗林有效地通过抑制从瑞诺丁受体释放来控制恶性热升高症. 一种新的亲水性配方可能会改善这种危及生命的疾病的静脉注射.
科学领域:
- 药理学 药理学是指药理学的学科.
- 麻醉学 麻醉学
- 生物化学 生物化学
背景情况:
- 丹特罗林 (DS) 最初是一种口服抗药.
- 它在1975年通过静脉注射成为恶性高温症 (MH) 的首要治疗方法.
- 对MH进行静脉注射的DS管理可能具有挑战性.
研究的目的:
- 审查丹特二的药理性质.
- 讨论它的应用,禁忌,副作用和药物相互作用.
- 为了突出最近在DS配方方面的进展.
主要方法:
- 参考文章的文献评论.参考文章的文献评论.
- 对丹罗的药理学数据的分析.
- 检查氨酸受体 (RyR) 功能.
主要成果:
- DS抑制了从瑞诺丁受体 (RyRs) 释放的Ca2+.
- RyRs涉及到MH和其他疾病,如心律不整和阿尔茨海默病.
- 已经开发出了DS的新型水友性配方.
结论:
- 麻醉师必须了解DS药理学,以管理MH.
- 由于其对RyRs的影响,DS在MH之外具有潜在的治疗应用.
- 最近的配方改进可能会解决管理方面的挑战.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
703
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
703
Skeletal Muscle Relaxants: Therapeutic Uses
511
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
511
Skeletal Muscle Relaxants: Adverse Effects
398
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
398
Heart Failure Drugs: Inotropic Agents
617
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
617
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
455
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
455


